JUNS
NASDAQ · Pharmaceuticals
Jupiter Neurosciences Inc
$2.20
+0.07 (+3.29%)
Open$2.10
Previous Close$2.13
Day High$2.27
Day Low$2.01
52W High$103.50
52W Low$2.05
Volume—
Avg Volume21.2K
Market Cap2.90M
P/E Ratio—
EPS$-18.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,896.8% upside
Current
$2.20
$2.20
Target
$43.93
$43.93
$31.75
$43.93 avg
$69.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.2K | 191.8K | 3.89M |
| Net Income | -24,693,391 | -68,487,062 | 896.5K |
| Profit Margin | -39,655.5% | -37,672.7% | 23.1% |
| EBITDA | -25,447,057 | -74,498,317 | 1.23M |
| Free Cash Flow | — | — | 754.2K |
| Rev Growth | -67.6% | -67.6% | +2.3% |
| Debt/Equity | 0.04 | 0.04 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |